This biotech's stock soared after a 'polarizing' FDA official is stepping down
Vinay Prasad, an official for the Food and Drug Administration, is reportedly stepping down, which is welcome news for biotech companies.
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
Here's what a handful of investing professionals say about the market's rapid recovery - and the fragile Middle East truce.
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse ArticlesVinay Prasad, an official for the Food and Drug Administration, is reportedly stepping down, which is welcome news for biotech companies.
Intellia Therapeutics Shares Rise 4.8% as FDA Lifts Clinical Hold
Vanda Pharmaceuticals stock surges after the FDA approves its new Bipolar I drug
US FDA reverses course, will review ModernaâEUR(TM)s flu vaccine application
Novocure shares surge after FDA approves pancreatic cancer device
Hims & Hers to stop offering compounded semaglutide pill after FDA crackdown
Some drugmakers quietly concerned about legal risk with speedy FDA review program
Eli Lilly shares dip as FDA delays decision on weight-loss pill
US FDA requests removal of suicide warnings from weight-loss drug labels
Plus Therapeutics stock falls after FDA meeting on REYOBIQ trial
MoonLake stock soars after FDA feedback on HS treatment path
The FDA no longer requires a safety warning on hormone-replacement therapies, at a time when more attention is being paid to perimenopause and menopause.